Welcome to the international HTA database

Showing [17111 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	National Institute for Health and Care Excellence (NICE)	Everolimus for advanced renal cell carcinoma after previous treatment. NICE technology appraisal guidance 432
2017	National Institute for Health and Care Excellence (NICE)	Apremilast for treating active psoriatic arthritis. NICE technology appraisal guidance 433
2016	NIHR Health Technology Assessment programme	Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Intrathecal idursulfase (Elaprase) for Hunter syndrome (mucopolysaccharidosis type II)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nusinersen for paediatric-onset spinal muscular atrophy – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for refractory myasthenia gravis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Voke 0.45mg inhaler for smoking cessation – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Crisaborole for adults, adolescents and children with atopic dermatitis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Netarsudil for open-angle glaucoma or ocular hypertension
2016	NIHR Health Technology Assessment programme	The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Mitomycin ophthalmic (Mitosol) for glaucoma surgery
2016	NIHR Health Services and Delivery Research programme	Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventions
2016	NIHR Health Services and Delivery Research programme	Integrated care to address the physical health needs of people with severe mental illness: a rapid review
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	An enhanced recovery after surgery program for hip and knee arthroplasty
2016	NIHR Health Technology Assessment programme	Modelling disease progression in relapsing remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort
2016	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	LINX reflux management system
2016	Agency for Healthcare Research and Quality (AHRQ)	Diabetes medications for adults with type 2 diabetes: an update
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cryotherapy, radioablation and irreversible electroporation for prostate cancer
2016	Agency for Healthcare Research and Quality (AHRQ)	Imaging for the pretreatment staging of small cell lung cancer
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	CT to reduce negative appendectomy rates
2016	Belgian Health Care Knowledge Centre (KCE)	Left ventricular assist devices in the treatment of end-stage heart failure
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Retrograde endovascular balloon occlusion of the aorta (REBOA)
2016	NIHR Health Technology Assessment programme	UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	MicroVisualase Thermal Therapy System: MRI-guided laser ablation of neurologic tumourswave ablation for liver tumours
2016	NIHR Public Health Research (PHR) programme	Interventions to promote or maintain physical activity during and after the transition to retirement: an evidence synthesis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Health Policy Advisory Committee on Technology (HealthPACT)
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Radiofrequency ablation for treating nasal hypertrophy of the inferior turbinates
2016	HAYES, Inc.	Balloon sinuplasty for treatment of chronic rhinosinusitis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SureFire Precision Chemoembolization Infusion system keeps drugs within liver tumours
2016	HAYES, Inc.	Comparative effectiveness of bivalirudin versus heparin monotherapy for percutaneous coronary intervention (PCI)
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Argus II Retinal prosthesis
2016	Health Information and Quality Authority (HIQA)	A guide to health technology assessment at HIQA
2016	HAYES, Inc.	Electrical bone growth stimulation, invasive
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	BioZorb - an implantable device to delimit surgical site after lumpectomy in breast cancer
2016	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Wireless technology for LV pacing without coronary sinus
2016	NIHR Health Technology Assessment programme	Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)
2016	HAYES, Inc.	Hyperbaric oxygen therapy for sudden sensorineural hearing loss
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Non-invasive open ventilation system
2016	NIHR Health Technology Assessment programme	The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, stakeholder focus groups and feasibility randomised controlled trial
2016	HAYES, Inc.	Indwelling pleural catheters for the management of malignant pleural effusions
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ovation iX Abdominal Stent Graft System
2016	HAYES, Inc.	Minimally invasive surgical (MIS) procedures for treatment of atrial fibrillation
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Bioresorbable stents
2016	HAYES, Inc.	Minimally invasive transforaminal lumbar interbody fusion (mitlif) versus open transforaminal lumbar interbody fusion (otlif) for treatment of lumbar disc disease: a review of reviews
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2016	NIHR Health Services and Delivery Research programme	Equity of utilisation of cardiovascular care and mental health services in England: a cohort-based cross-sectional study using small-area estimation
2016	HAYES, Inc.	Nitric oxide breath analysis for the management of asthma
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ga-68 prostate specific membrane antigen (PSMA) PET/CT
2016	NIHR Horizon Scanning Centre (NIHR HSC)	AXS 02 (zoledronic acid) for type I complex regional pain syndrome
2016	HAYES, Inc.	Noninvasive computed fractional flow reserve from computed tomography (FFRCT) for coronary artery disease
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease – patients in remission
2016	HAYES, Inc.	Noninvasive electrical bone growth stimulators for spinal fusion or foot and ankle indications
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Duvelisib for relapsed chronic lymphocytic leukaemia – second and subsequent line
2016	HAYES, Inc.	Patient-specific instruments for total knee arthroplasty: a review of reviews
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Duvelisib for relapsed follicular lymphoma - third and subsequent line
2016	HAYES, Inc.	Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2016	HAYES, Inc.	5-aminolevulinic acid photodynamic therapy versus carbon dioxide laser ablation for the treatment of condylomata acuminata
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for relapsed or refractory peripheral T-cell lymphoma
2016	HAYES, Inc.	Amniotic tissue–derived allografts for treatment of plantar fasciitis
2016	NIHR Health Technology Assessment programme	The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study
2016	NIHR Health Services and Delivery Research programme	Outpatient services and primary care: scoping review, substudies and international comparisons
2016	HAYES, Inc.	Bupivacaine liposome injectable suspension (Exparel; Pacira Pharmaceuticals Inc.) for treatment of postoperative pain in abdominal surgeries
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ursodeoxycholic acid (Ursofalk®)
2016	HAYES, Inc.	Carbon dioxide (CO2) laser ablation versus other surgical treatment of condylomata acuminata
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eribulin mesilate (Halaven®)
2016	HAYES, Inc.	Fecal microbiota transplant for refractory or recurrent Clostridium difficile infection in adults
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sorafenib (Nexavar®)
2016	HAYES, Inc.	Intersitial brachytherapy for the treatment of nonmelanoma skin cancer
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ulipristal acetate (Esmya®)
2016	Agency for Healthcare Research and Quality (AHRQ)	Omega-3 fatty acids and cardiovascular disease: an updated systematic review
2016	HAYES, Inc.	Laser balloon ablation for treatment of atrial fibrillation
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Prucalopride (Resolor®)
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies to de-escalate aggressive behavior in psychiatric patients
2016	HAYES, Inc.	Low frequency right transcranial magnetic stimulation for major depressive disorder
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lefitolimod for extensive small cell lung cancer – maintenance therapy
2016	Health Quality Ontario (HQO)	Composite tissue transplant of hand or arm: a health technology assessment
2016	HAYES, Inc.	Magnetic resonance-guided focused ultrasound therapy (ExAblate 2000; InSightec Ltd.) for ablation of uterine fibroids
2016	NIHR Health Technology Assessment programme	Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers
2016	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Fostamatinib for chronic immune thrombocytopenic purpura
2016	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2016	HAYES, Inc.	NanoKnife system for irreversible electroporation treatment of locally advanced pancreatic cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Daratumumab with bortezomib and dexamethasone for relapsed or refractory multiple myeloma – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Reparixin for prevention of delayed graft function in pancreatic islet transplantation for type 1 diabetes mellitus
2016	Health Quality Ontario (HQO)	Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2016	HAYES, Inc.	NanoKnife system for irreversible electroporation treatment of primary and metastatic liver tumors
2016	NIHR Horizon Scanning Centre (NIHR HSC)	IMA-901 for locally advanced or metastatic renal cell carcinoma ─ first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Bezlotoxumab for treatment and prevention of recurrence of Clostridium difficile infection
2016	Health Quality Ontario (HQO)	Women's experiences of inaccurate breast cancer screening results: a systematic review and qualitative meta-synthesis
2016	HAYES, Inc.	Surface brachytherapy for the treatment of nonmelanoma skin cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Alicaforsen for active ulcerative colitis – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Cadazolid for treatment of Clostridium difficile-associated diarrhoea
2016	Health Quality Ontario (HQO)	Fecal microbiota therapy for clostridium difficile infection: a health technology assessment
2016	HAYES, Inc.	UroLift System (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2016	NIHR Health Technology Assessment programme	Bladder ultrasound for diagnosing detrusor overactivity: test accuracy study and economic evaluation
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Fenfluramine for Dravet syndrome – first line